Recruiting
Phase 3

Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy

Sponsor:

Italfarmaco

Code:

NCT05933057

Conditions

Duchenne Muscular Dystrophy

Eligibility Criteria

Sex: Male

Age: 9 - 17

Healthy Volunteers: Not accepted

Interventions

Givinostat

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information